logo
Weather page
GET THE APP
ePaper
google_play
app_store
  • Login
  • E-Edition
  • Sports
  • Obits
  • News
  • Opinion
  • Classifieds
    • Place an Ad
    • All Listings
    • Jobs
  • SPECIAL SECTIONS
  • GALLERY
  • CONTESTS
  • LIFESTYLE/ENTERTAINMENT
  • GAMES
  • Allegany County Source
    • News
      • local
      • state
      • nation/world
    • Sports
      • local
      • college
      • State
      • national
    • obits
    • Opinion
      • News
        • local
        • state
        • nation/world
      • Sports
        • local
        • college
        • State
        • national
      • obits
      • Opinion
    logo
    • Classifieds
      • Place an Ad
      • All Listings
      • Jobs
    • E-Edition
    • Subscribe
    • Login
      • Classifieds
        • Place an Ad
        • All Listings
        • Jobs
      • E-Edition
      • Subscribe
      • Login
    Home

    Olean Times Herald

    Posts
    Everest Medicines Announces Financial Results for Full Year Ended December 31, 2024
    Press Releases
    Everest Medicines Announces Financial Results for Full Year Ended December 31, 2024
    Everest Medicines 
    March 26, 2025
    SHANGHAI , March 25, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the di...
    Read More...
    {"website":"Website"}
    Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14
    Press Releases
    Everest Medicines Announces FDA Clearance of IND Application for Tumor-Associated Antigen Vaccine EVM14
    Everest Medicines 
    March 23, 2025
    SHANGHAI , March 23, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the di...
    Read More...
    {"website":"Website"}
    Everest Medicines Announces First Patient Dosed with EVM16, Its First Internally Developed Personalized mRNA Cancer Vaccine
    Press Releases
    Everest Medicines Announces First Patient Dosed with EVM16, Its First Internally Developed Personalized mRNA Cancer Vaccine
    Everest Medicines 
    March 6, 2025
    SHANGHAI , March 6, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the dis...
    Read More...
    {"website":"Website"}
    Everest Medicines to Hold Investor Calls with Updates on mRNA Therapeutic Vaccine Programs
    Press Releases
    Everest Medicines to Hold Investor Calls with Updates on mRNA Therapeutic Vaccine Programs
    Everest Medicines 
    February 28, 2025
    SHANGHAI , Feb. 28, 2025 /PRNewswire/ --Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on discover...
    Read More...
    {"website":"Website"}
    Everest Medicines to Announce Full-Year 2024 Financial Results on March 26, 2025
    Press Releases
    Everest Medicines to Announce Full-Year 2024 Financial Results on March 26, 2025
    Everest Medicines 
    February 25, 2025
    SHANGHAI , Feb. 25, 2025 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the dis...
    Read More...
    {"website":"Website"}
    Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy
    Press Releases
    Everest Medicines Announces Positive Results in Preliminary Analysis of Phase 1b/2a Clinical Trial of EVER001, a Novel BTK Inhibitor for the Treatment of Primary Membranous Nephropathy
    Everest Medicines 
    December 4, 2024
    SHANGHAI , Dec. 3, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK,"Everest", or the "Company"), a biopharmaceutical company focused on the disco...
    Read More...
    {"website":"Website"}
    Everest Medicines to Hold Investor Calls on Data Results from EVER001 Phase 1b/2a Clinical Study in Primary Membranous Nephropathy
    Press Releases
    Everest Medicines to Hold Investor Calls on Data Results from EVER001 Phase 1b/2a Clinical Study in Primary Membranous Nephropathy
    Everest Medicines 
    November 27, 2024
    SHANGHAI , Nov. 27, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the dis...
    Read More...
    {"website":"Website"}
    Local & Social

    Get in touch with Olean Times Herald

    Submit Content
    Send a Letter to the Editor Place Wedding Announcement Place Engagement Announcement
    Advertise
    Place Birth Announcement Place Anniversary Announcement Place Obituary
    Subscribe
    Start a Subscription e-Edition Contact Us
    Illinois Hancock Journal-Pilot Iroquois Times-Republic Journal-Republican The News-Gazette
    Indiana Fountain Co. Neighbor Herald Journal KV Post News Newton Co. Enterprise Rensselaer Republican Review-Republican
    Iowa Atlantic News Telegraph Audubon Advocate-Journal Barr's Post Card News Burlington Hawk Eye Collector's Journal Fayette County Union Ft. Madison Daily Democrat Independence Bulletin-Journal Keokuk Daily Gate City Oelwein Daily Register Vinton Newspapers Waverly Newspapers
    Michigan Iosco County News-Herald Ludington Daily News Oceana's Herald-Journal Oscoda Press White Lake Beacon New York Finger Lakes Times Olean Times Herald Salamanca Press
    Pennsylvania Bradford Era Clearfield Progress Courier Express Free Press Courier Jeffersonian Democrat Leader Vindicator Potter Leader-Enterprise The Wellsboro Gazette
    © Copyright Olean Times Herald 639 Norton Drive, Olean, NY 14760  | Terms of Use  | Privacy Policy
    Powered by TECNAVIA